We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
276
Zimmer Biomet
ZBH
$18.2B
$2.24M 0.06%
17,728
+15,455
+680% +$1.91M
MET icon
277
MetLife
MET
$61.9B
$2.21M 0.05%
55,934
-1,206
-2% -$45.3K
LNC icon
278
Lincoln National
LNC
$8.72B
$2.15M 0.05%
45,749
-1,135
-2% -$50.8K
SPY icon
279
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$2.03M 0.05%
9,385
-509
-5% -$110K
GD icon
280
General Dynamics
GD
$104B
$2.01M 0.05%
12,948
-71,393
-85% -$10.6M
FCNCA icon
281
First Citizens BancShares
FCNCA
$24.9B
$2.01M 0.05%
+6,826
New +$1.86M
TGNA
282
DELISTED
TEGNA Inc
TGNA
$1.97M 0.05%
140,594
-41,231
-23% -$580K
RJF icon
283
Raymond James Financial
RJF
$33.8B
$1.96M 0.05%
50,429
-1,405
-3% -$51.8K
EFA icon
284
iShares MSCI EAFE ETF
EFA
$78B
$1.94M 0.05%
32,824
-1,995
-6% -$116K
DUK icon
285
Duke Energy
DUK
$97.8B
$1.94M 0.05%
24,221
+103
+0.4% +$8.53K
UNP icon
286
Union Pacific
UNP
$174B
$1.9M 0.05%
19,455
-169
-0.9% -$15.8K
ECON icon
287
Columbia Emerging Markets Consumer ETF
ECON
$328M
$1.89M 0.05%
76,214
+32,422
+74% +$799K
AIG icon
288
American International
AIG
$41.7B
$1.89M 0.05%
31,870
-3,232
-9% -$185K
MPC icon
289
Marathon Petroleum
MPC
$92.4B
$1.89M 0.05%
46,595
+10,274
+28% +$417K
KO icon
290
Coca-Cola
KO
$377B
$1.86M 0.05%
43,989
EFSC icon
291
Enterprise Financial Services Corp
EFSC
$2.4B
$1.84M 0.05%
+59,020
New +$1.75M
GOOG icon
292
Alphabet (Google) Class C
GOOG
$4.36T
$1.8M 0.04%
46,400
+680
+1% +$25.8K
CTB
293
DELISTED
Cooper Tire & Rubber Co.
CTB
$1.8M 0.04%
47,321
-2,929
-6% -$98K
USIG icon
294
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$1.78M 0.04%
31,248
+2,484
+9% +$141K
IGIB icon
295
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$1.74M 0.04%
31,166
-1,272
-4% -$70.8K
ILMN icon
296
Illumina
ILMN
$31B
$1.72M 0.04%
+9,717
New +$1.55M
AMED
297
DELISTED
Amedisys
AMED
$1.66M 0.04%
35,071
-1,616
-4% -$80.6K
CRL icon
298
Charles River Laboratories
CRL
$11.2B
$1.66M 0.04%
19,965
+15,895
+391% +$1.33M
VCIT icon
299
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$1.66M 0.04%
18,527
+815
+5% +$72.9K
HIG icon
300
Hartford Financial Services
HIG
$38.9B
$1.61M 0.04%
37,633
-121,970
-76% -$5.1M

Similar funds

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.